PROCEPT BioRobotics Corporation PRCT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$31.64M-6.0% | -$29.85M-39.4% | -$21.41M-9.4% | -$19.58M+20.9% | -$24.74M-31.2% | ||
| $1.74M+1.5% | $1.71M+5.6% | $1.62M+1.9% | $1.59M+7.7% | $1.48M+1.5% | ||
| $13.07M+20.6% | $10.84M-25.2% | $14.49M+19.1% | $12.16M+20.3% | $10.11M+11.3% | ||
| $274K— | —— | $526K-7.7% | $570K+72.7% | $330K-14.1% | ||
| $13.32M— | —— | $4.35M— | —— | -$3.93M-126% | ||
| $7.03M+75.8% | $4M— | $0-100% | $4.79M-23.8% | $6.28M+8.4% | ||
| $1.54M-74.1% | $5.93M— | —— | —— | $3.75M+170% | ||
| -$1.17M-371% | $431K-75.5% | $1.76M+443% | -$513K+10.9% | -$576K-129% | ||
| $180K-90.1% | $1.83M— | —— | $1.17M+200% | $390K+102% | ||
| $628K-67.9% | $1.95M+73.1% | $1.13M— | $0-100% | $235K-83.5% | ||
| —— | -$39.25K0.0% | -$39.25K0.0% | -$39.25K0.0% | -$39.25K— | ||
| -$4.69M-439% | $1.38M-74.6% | $5.46M+315% | $1.31M+120% | -$6.56M-343% | ||
| -$38.13M-269% | -$10.33M-55.6% | -$6.64M+55.9% | -$15.04M+11.4% | -$16.98M+47.6% | ||
| $2.91M+57.5% | $1.85M-35.5% | $2.87M+2.4% | $2.8M+52.6% | $1.84M+56.4% | ||
| -$2.91M-57.5% | -$1.85M+35.5% | -$2.87M-2.4% | -$2.8M-52.6% | -$1.84M-56.4% | ||
| $222K+107% | -$3.25M-401% | $1.08M+23.5% | $873K-32.7% | $1.3M-99.2% | ||
| $222K-95.0% | $4.44M+312% | $1.08M-75.4% | $4.38M+237% | $1.3M-99.2% | ||
| -$42K-2.4% | -$41K-310% | -$10K+56.5% | -$23K— | $0— | ||
| -$40.86M-425% | -$7.78M+7.8% | -$8.44M+37.5% | -$13.49M+23.0% | -$17.52M-113% | ||
| $801K-3.6% | $831K-5.4% | $878K+1.0% | $869K-1.8% | $885K-4.2% | ||
| -$4.69M-439% | $1.38M-74.6% | $5.46M+315% | $1.31M+120% | -$6.56M-343% | ||
| $49K+2.1% | $48K+14.3% | $42K+55.6% | $27K+8.0% | $25K-26.5% | ||
| $431K-53.3% | $922K+14.1% | $808K+4.9% | $770K+94.9% | $395K-69.7% | ||
| -$1.17M-371% | $431K-75.5% | $1.76M+443% | -$513K+10.9% | -$576K-129% | ||
| $195K— | $0-100% | $76K-60.0% | $190K-36.7% | $300K-50.0% | ||
| $159K+25.2% | $127K0.0% | $127K0.0% | $127K0.0% | $127K+32.3% | ||
| $274K— | —— | $526K-7.7% | $570K+72.7% | $330K-14.1% | ||
| $1.06M+316% | $255K+152% | $101K— | —— | $1.39M+330% | ||
| -$42K-2.4% | -$41K-310% | -$10K+56.5% | -$23K— | $0— | ||
| -$297K— | —— | —— | $348K— | $0— | ||
| $628K-67.9% | $1.95M+73.1% | $1.13M— | $0-100% | $235K-83.5% | ||
| -$41.04M-237% | -$12.18M-28.1% | -$9.5M+46.7% | -$17.85M+5.2% | -$18.82M+43.9% | ||
| -$41.04M-237% | -$12.18M-28.1% | -$9.5M+46.7% | -$17.85M+5.2% | -$18.82M+43.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does PROCEPT BioRobotics Corporation generate?
- PROCEPT BioRobotics Corporation (PRCT) generated -$70.1M in operating cash flow over the trailing twelve months.
- What is PROCEPT BioRobotics Corporation's free cash flow?
- After $10.4M of capital expenditures, PROCEPT BioRobotics Corporation's free cash flow was -$80.6M over the trailing twelve months, up 8.7% year over year.
- Where does PROCEPT BioRobotics Corporation's cash flow data come from?
- Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
